Bryer E, Mintzer D, Henry DH: 2019 At a Glance: Hem-Onc U.S. Drug Approvals MDedge/Hematology and Oncology : 2019.
Emily Bryer, Monique Neault, David Mintzer: Managing Dying: Medical Care and Decision Making at the Very End-of-Life Palliative Medicine & Care: Open Access : DOI: http://dx.doi.org/10.15226/2374-8362/6/1/00180,2019.
Bryer E, Mintzer D, Henry D: 2018 At A Glance: Recently Approved Therapies in Oncology MD Edge/Hematology and Oncology : ://mdedge-files-live.s3.us-east-2.amazonaws.com,2019.
Deshields TL, Dueck AC, Rogers K, Brown JR, Shanafelt T, Mintzer D, Byrd JC: Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). Leukemia and Lymphoma : 1-4,2019.
Mintzer D.: MKSAP Oncology, Sections on melanoma, lymphoma, survivorship/complications of chemotherapy ACP 17 : 2018.
Deye D, Mintzer D: ACP MKSAP 18 Audio Companion-- Oncology Oakstone : 2018.
Mintzer DM.: 2017 Notches Up Some Landmark Approvals Journal of Community and Supportive Oncology 15 (6): e346,2017.
Granda-Cameron C, Behta M, Hovinga M, Rundio A, Mintzer D.: Risk factors associated with unplanned hospital readmissions in adults with cancer. Oncol Nurs Forum 42 (3): E257-68,2015.
Mintzer, D.: Generalizations of a generalist Journal of Community and Supportive Oncology 13 (9): 337-340,2015.
Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJ, Daber R, Bagg A.: BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia. Blood 122 (17): 3084-5,2013.